Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$7.82 USD
-0.26 (-3.22%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.81 -0.01 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IRWD 7.82 -0.26(-3.22%)
Will IRWD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IRWD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRWD
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
IRWD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
Ironwood (IRWD) is on the Move, Here's Why the Trend Could be Sustainable
Wall Street Analysts Think Ironwood (IRWD) Could Surge 37.6%: Read This Before Placing a Bet
Other News for IRWD
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
Analysts Are Bullish on Top Healthcare Stocks: BioCryst (BCRX), Ironwood Pharma (IRWD)
First Week of June 21st Options Trading For Ironwood Pharmaceuticals (IRWD)
Ironwood management to meet with Craig-Hallum
Ironwood management to meet with Craig-Hallum